Gupta Ashok K
USPTO Trademark & Patent Filings
Trademark applications and grants for Gupta Ashok K. Gupta Ashok K has 1 trademark applications. The latest application filed is for "METROTHERAPY"
- Company Aliases
- Gupta, Ashok K
- k ashok gupta
- Gupta; Ashok K. - Clarksburg MD
- Gupta; Ashok K. - Plainsboro NJ
Trademarks Patents
| Patent Application | Date |
|---|---|
| CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING 20200308282 - 16/827580 COGSWELL; John P. ; et al. | 2020-10-01 |
| CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING 20190153099 - 16/248215 COGSWELL; John P. ; et al. | 2019-05-23 |
| CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING 20190135920 - 16/248222 Cogswell; John P. ; et al. | 2019-05-09 |
| CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING 20190112377 - 16/231211 COGSWELL; John P. ; et al. | 2019-04-18 |
| CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING 20190112376 - 16/230657 COGSWELL; John P. ; et al. | 2019-04-18 |
| Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer 10,688,180 - 15/703,126 Graziano , et al. | 2020-06-23 |
| Cancer immunotherapy by disrupting PD-1/PD-L1 signaling 10,604,575 - 16/231,211 Cogswell , et al. | 2020-03-31 |
| Cancer immunotherapy by disrupting PD-1/PD-L1 signaling 10,584,170 - 16/248,215 Cogswell , et al. | 2020-03-10 |
| Cancer immunotherapy by disrupting PD-1/PD-L1 signaling 10,577,423 - 16/248,222 Cogswell , et al. | 2020-03-03 |
| Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma 10,494,433 - 15/032,919 Andre , et al. De | 2019-12-03 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"METROTHERAPY" 78359438 |
METROTHERAPY 2004-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 